NEW YORK (GenomeWeb News) – Lophius Biosciences today said that it has joined a research consortium that will work with the firm on developing its T-Track MS diagnostic test for initial diagnosis of multiples sclerosis and monitoring of disease progression.

The project is part of the NEU2 program and has received funding of €350,000 ($468,800) from Germany's Federal Ministry of Education and Research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.